Axxion S.A.’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Axxion S.A.'s VRTX Position: Q3 2026 in Review
Axxion S.A. held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 1,605 shares worth $839K. The position accounts for 0.06% of the portfolio, ranked #172.
Axxion S.A. first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 1,786 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Axxion S.A. held 1,605 shares of Vertex Pharmaceuticals worth $839K as of Q3 2026.
- Axxion S.A. left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
- Vertex Pharmaceuticals made up 0.06% of Axxion S.A.'s portfolio in Q3 2026, its #172 holding.
- Axxion S.A. first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- 1,786 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Axxion S.A.'s 13F filing for Q3 2026, filed 22 Oct 2026.